Skip to content
Patient Resources ยท Lipid Disorders

What is ApoB โ€” and why can it matter more than LDL?

A plain-language guide to apolipoprotein B: what it measures, when it's more accurate than LDL cholesterol, who should be tested, and how to lower a high result.

One particle, one ApoB ApoB counts the number of artery-damaging cholesterol particles in your blood โ€” not the cholesterol they happen to be carrying.
Medicare covered ApoB testing is bulk-billed in Australia when ordered by your doctor โ€” no fasting needed, no extra cost.
Most useful whenโ€ฆ Triglycerides are high, there's metabolic syndrome or diabetes, or treatment decisions feel finely balanced.
One ApoB protein per artery-damaging particle A diagram showing a single LDL cholesterol particle in cross-section, with one ApoB protein wrapped around its surface. Below it, a row of five particles, each carrying exactly one ApoB. ONE PROTEIN, ONE PARTICLE A single LDL particle One ApoB protein wraps every artery-damaging particle. ApoB protein structural; one per particle Cholesterol cargo amount varies particle to particle COUNT THEM TO COUNT THE RISK โ€ฆ
Each artery-damaging particle carries exactly one ApoB. Measuring ApoB counts the particles, not the cholesterol they happen to be carrying.
In one paragraph

Your standard cholesterol test measures how much cholesterol is being carried in your blood. An ApoB test counts how many particles are doing the carrying. Two people with identical LDL cholesterol can have very different ApoB levels โ€” and the one with more particles has higher cardiovascular risk. ApoB is a refinement to, not yet a replacement for, LDL cholesterol โ€” most useful when triglycerides are elevated, when there's a strong family history of early heart disease, or when the treatment decision feels finely balanced.

What is ApoB?

ApoB โ€” short for apolipoprotein B โ€” is the structural protein wrapped around every "atherogenic" cholesterol particle in your bloodstream. Atherogenic simply means capable of forming the plaque that narrows arteries.

The particles that carry this label include LDL (the so-called bad cholesterol), VLDL, IDL, remnant particles, and lipoprotein(a) or Lp(a).

The important detail is that each of these particles carries exactly one ApoB molecule. So when a laboratory measures your ApoB concentration, it's effectively counting the number of artery-damaging particles circulating in your blood โ€” not how much cholesterol they happen to be carrying that day.

Plaque doesn't form when cholesterol enters an artery wall. Plaque forms when particles enter the artery wall and get trapped. The number of particles is the more direct measure of risk.

Why ApoB can matter more than LDL

For most people, LDL cholesterol and ApoB tell the same story. They correlate strongly. If your LDL is high, your ApoB is usually high too.

The problem is the people for whom the two measurements disagree โ€” a situation lipid specialists call discordance. It typically happens in three settings:

1. High triglycerides, metabolic syndrome, or type 2 diabetes

These conditions favour smaller, cholesterol-poor LDL particles. Each particle carries less cholesterol, so LDL-C can look reassuringly normal while the particle count (ApoB) is high.

2. On statin or ezetimibe therapy

These medicines clear larger, cholesterol-rich particles preferentially. LDL-C falls more than ApoB does โ€” meaning some patients reach an "on-target" LDL but still carry higher residual risk than the LDL number suggests.

3. Elevated Lp(a)

Lp(a) is itself an ApoB-containing particle, so a high Lp(a) pushes ApoB up independent of LDL.

When LDL and ApoB disagree โ€” risk follows the ApoB A two-by-two grid showing the four possible combinations of low or high LDL cholesterol and low or high ApoB. The two scenarios with high ApoB carry elevated cardiovascular risk regardless of LDL level. The two with low ApoB carry low risk regardless of LDL level. DISCORDANCE When the two tests disagree, risk follows the ApoB Four scenarios. The number of particles (ApoB) decides the risk โ€” not the cholesterol they carry (LDL). LOW LDL HIGH LDL HIGH APOB LOW APOB Many small particles LDL normal, particle count high ! HIGH RISK Many large particles Both numbers high โ€” classic risk ! HIGH RISK Few small particles Both numbers low โ€” reassuring LOW RISK Few large particles LDL high, particle count low LOW RISK In the two left-hand cells, LDL and ApoB tell different stories. The clinical evidence shows risk follows the ApoB.
The four combinations of LDL and ApoB. Risk tracks with the row, not the column โ€” high ApoB means high risk regardless of where LDL sits.
When LDL and ApoB disagree, the risk follows the ApoB. This has been shown in the Copenhagen General Population Study and in analyses of large statin and PCSK9 inhibitor trials (IMPROVE-IT, FOURIER, ODYSSEY OUTCOMES). That said, every randomised treatment trial we have was designed around LDL targets โ€” so ApoB is best used to refine treatment decisions, not yet replace the LDL target.

Who should consider an ApoB test?

ApoB isn't needed by everyone with high cholesterol. For most people, a standard lipid panel gives all the information needed to make a treatment decision. ApoB earns its place in specific situations.

Most useful

High triglycerides โ€” when triglycerides are above 1.7 mmol/L, calculated LDL becomes less reliable. ApoB sees through this and gives an accurate particle count.

Metabolic syndrome or diabetes โ€” insulin resistance favours small, cholesterol-poor LDL. ApoB catches the elevated particle count that LDL-C may miss.

Family history of early heart disease โ€” an elevated ApoB despite borderline LDL can be the missing piece of the risk picture.

Sometimes useful

Already on a statin โ€” if your LDL is "on target" but residual risk is a concern, ApoB can clarify whether to intensify therapy.

Borderline treatment decision โ€” when the choice between starting a statin and continuing lifestyle measures feels finely balanced, a low ApoB can reasonably defer therapy; a high ApoB pushes the other way.

Cascade screening โ€” helps identify family members who carry an inherited lipid disorder like familial combined hyperlipidaemia.

Good news for Australian patients. ApoB testing is covered by Medicare when ordered by your doctor โ€” there's no out-of-pocket cost at most pathology labs, no special preparation is needed, and you do not need to fast. It can be added to a standard lipid panel from the same blood draw.

What are healthy ApoB levels?

ApoB is reported in grams per litre (g/L) in Australia, though some labs and international guidelines use milligrams per decilitre (mg/dL). The two are equivalent โ€” multiply g/L by 100 to convert to mg/dL.

Target levels depend on your overall cardiovascular risk. The thresholds below are from the 2024 National Lipid Association consensus and align with the ACC/AHA LDL-C treatment bands:

Your risk category ApoB target What this typically means
Very high risk < 0.6 g/L
(< 60 mg/dL)
Previous heart attack, stroke, stent or bypass; or multiple risk factors with established artery disease
High risk < 0.7 g/L
(< 70 mg/dL)
Diabetes with risk factors, severe familial hypercholesterolaemia, or 10-year cardiovascular risk above 20%
Borderline / intermediate risk < 0.9 g/L
(< 90 mg/dL)
10-year cardiovascular risk roughly 5โ€“20%, or LDL above 4.9 mmol/L
General population < 1.0 g/L
(< 100 mg/dL)
Below average cardiovascular risk; no specific risk factors

An ApoB above 1.3 g/L sits in roughly the top 10% of the adult population and is itself a risk-enhancing factor. At that level, treatment is usually recommended regardless of what the LDL number says.

How to lower a high ApoB

The interventions that lower ApoB are the same ones that lower LDL cholesterol โ€” because they reduce the number of artery-damaging particles in circulation. The order matters: lifestyle first, then medication when risk warrants it.

Saturated fat โ€” butter, fatty meats, full-fat dairy, coconut and palm oils
Mediterranean-pattern eating โ€” olive oil, fish, nuts, legumes, vegetables
Refined carbohydrates and sugary drinks
Soluble fibre โ€” oats, psyllium, beans, lentils
Sedentary days
~150 minutes per week of aerobic exercise
Smoking
Quitting โ€” improves HDL and substantially reduces overall risk

When medication is needed

If risk is high enough that lifestyle alone won't reach target, the medication ladder is well established:

  • Statins are first line. Atorvastatin and rosuvastatin are the most commonly used. They lower ApoB by around 30โ€“40% at moderate-to-high doses and have decades of trial data supporting cardiovascular risk reduction.
  • Ezetimibe is usually the first add-on if statin therapy alone is insufficient โ€” it lowers ApoB by a further ~15%.
  • PCSK9 inhibitors (evolocumab, alirocumab, or twice-yearly inclisiran) are reserved for high-risk patients still above target on statin and ezetimibe. They can reduce ApoB by another 40% or more.
  • Bempedoic acid is an option for patients who genuinely can't tolerate statins.
On therapy, ApoB falls roughly in proportion to LDL, but slightly less โ€” by about 30โ€“40% on a statin alone, more with combination therapy. If your LDL is on target but your ApoB still isn't, that's exactly the discordance scenario where intensifying treatment can be worthwhile.

Frequently asked questions

Do I need to fast before an ApoB test?

No. Unlike triglycerides, ApoB levels barely change between the fasting and non-fasting state, so the test can be done at any time of day. If your doctor has ordered ApoB alongside a full lipid panel and triglycerides are part of that, fasting is sometimes still requested โ€” but increasingly, non-fasting lipid panels are considered acceptable.

If my LDL is normal, do I still need an ApoB test?

Usually no. For most people with a normal LDL and no specific risk factors, an ApoB test adds little. It becomes useful when there is something in the picture suggesting LDL might be misleading โ€” high triglycerides, metabolic syndrome, diabetes, low HDL, a strong family history, or an elevated Lp(a).

Should ApoB replace my LDL cholesterol test?

Not yet, and probably not soon. The randomised trials that established statin and PCSK9 inhibitor therapy were all designed around LDL-C targets, so LDL-C remains the primary treatment target in most guidelines. ApoB is best thought of as a refinement โ€” used alongside LDL-C to improve risk assessment, particularly in cases of discordance. This may change over the next decade as more evidence accumulates.

How much does ApoB change with diet?

Modestly. Diet and lifestyle changes typically reduce ApoB by around 5โ€“15% โ€” the same order of magnitude as the LDL reduction they produce. This can be enough on its own for someone at lower overall risk, but is usually inadequate for someone at high risk, who will also need medication.

What if my ApoB is high but my LDL is normal?

This is the classic "discordance" scenario and it's exactly when an ApoB test earns its place. A high ApoB with normal LDL indicates a higher cardiovascular risk than the LDL number suggests โ€” typically because of small, cholesterol-poor LDL particles. The clinical implication is that treatment decisions should follow the ApoB rather than the LDL.

The bottom line

ApoB counts particles, LDL measures cholesterol. Most of the time they agree. When they don't, the particle count is the more reliable measure of cardiovascular risk.
It's most useful when triglycerides are elevated, when there's metabolic syndrome or diabetes, when there's a strong family history of early heart disease, or when treatment decisions are finely balanced.
In Australia, ApoB testing is covered by Medicare and can be added to a standard lipid panel โ€” no fasting, no extra cost. If any of the situations above apply to you, it's reasonable to ask your doctor about adding ApoB next time you have a lipid test.
Personalised cardiac risk assessment

Discuss your lipid results with a cardiologist

If your ApoB or cholesterol results don't quite add up โ€” or you'd like a clearer picture of your cardiovascular risk โ€” Dr Reza Moazzeni provides comprehensive lipid and prevention assessment at Westmead and St Leonards. A GP referral is required for the Medicare rebate.

Book a consultation